INSM
INSMED Inc
NASDAQ · Healthcare · Biotechnology · US
$111.59
+15.06%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 137.32x
- P/E 2028E
- 34.47x
- P/S forward
- 9.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 32.17x
- Price / sales
- 21.42x
- Price / cash flow
- -31.29x
Enterprise value
- Enterprise value
- $23.8B
- EV / sales
- 20.91x
- EV / EBITDA
- -30.86x
- EV / EBIT
- -29.10x
- Market cap
- $24.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026